Adjuvant Partners is a life sciences transaction advisory company representing a portfolio of small-mid cap firms with clinical and pre-clincial programs in regenerative medicine and other advanced biotherapeutics. Many of our clients are working with stem cells in either therapeutic applications or drug discovery. Primary indications include cardiovascular disease, neuro-degenerative disorders, wound healing, cancer, and a number of orhpan indications. (BIOTECanada)